Maynard Um
-
-
-
-
-
-
-
Seres cuts workforce 30% as it pauses Phase 2 study investment
-
-
-
-
-
-
-
Seres Therapeutics names co-CEOs as current chief executive steps down
-
-
-
-
-
-
-
Seres Therapeutics (MCRB) Misses Q3 EPS by 25c
-
-
-
-
-
-
-
Seres Therapeutics (MCRB) Tops Q2 EPS by 5c
-
430,963 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

